I N T R O D U C T I O N
Schwann cells isolated from mammalian nerve trunks possess P2Y purinergic metabotropic receptors (primarily P2Y2) that respond to the exogenous application of ATP with a calcium transient derived from the release of this cation from internal stores (Ansselin et al. 1997; Berti-Mattera et al. 1996; Lyons et al. 1994 Lyons et al. , 1995 . Schwann cells "in vivo" also possess P2Y2 receptors, whether these are in close apposition to mammalian sensory endings (Takahashi-Iwanaga and Habara 2002) or amphibian and skate motor-nerve terminals (Green et al. 1997; Robitaille 1995) . The endogenous release of ATP from the nerve terminals also excites such receptors on amphibian Schwann cells to produce calcium transients due to intracellular calcium release (Robitaille 1995) . In addition, Schwann cells may possess iontotropic P2X receptors (Colomar and Amédée 2001) . For example, the Schwann cells in close apposition to mammalian C fibers produce calcium transients in response to applied ␣,␤-methylene ATP, a response that is blocked by pyridoxal-phosphate-6-azophenyl-2Ј,5Ј-disulphonic acid (PPADs), indicating probable activation of a P2X1 receptor (Irnich et al. 2001) .
Schwann cells (SCs) are in close apposition to mammalian sympathetic nerve terminal varicosities (Bennett and Merrillees 1966) , although they are not present around these varicosities toward the end of the terminal branches in the vas deferens and urinary bladder (Cottee et al. 1996; Gabella 1995) . These mammalian SCs, identified with antibodies to the Schwann cell antigen S100, possess P2X receptors that, according to immunohistochemical criteria, are principally of the P2X1 and P2X3 subtypes (Barden et al. 1999) . It is not known if these SCs also possess P2Y receptors. As ATP is a cotransmitter at sympathetic nerve terminals, the question arises as to whether the endogenous release of ATP stimulates ⌬ [Ca 2ϩ ] s in their SCs and if so what receptors are involved. The present work investigates this possibility.
M E T H O D S

Preparation and drugs
All experiments were performed on the vas deferens of mice (strain BALB/c), 5-6 wk old. Animals were anesthetized with CO 2 , then killed by cervical fracture. Animal ethics approval was granted by the Animal Care Ethics Committee, University of Sydney. Both vas deferentia were dissected free along with the connective tissue and placed into a dissection bath coated with silicone elastomer (Sylgard, Dow Corning, Midland, MI) in the bottom of a Perspex chamber and immersed in Ringer solution. The Ringer solution contained (in mM) 136.9 NaCl, 2.7 KCl, 14.9 NaHCO 3 , 1.5 NaH 2 PO 4 , 1 MgCl 2 , 2 CaCl 2 , and 7.8 glucose. This solution was always oxygenated with a mixture of 95% O 2 -5% CO 2 to maintain the pH between 7.1 and 7.4. After carefully removing connective tissue from the surface of the vas deferens, a longitudinal cut was made along its length so as to allow it to be pinned out as a rectangular sheet in the bath solution. From this point, the preparations were left in fresh Ringer solution for ϳ30 -60 min at room temperature (18 -20°C) before carrying out any further procedures.
All drugs used were from Sigma products (Sigma, Australia). Apyrase, ATP, caffeine, EGTA, and suramin (sodium salt) were prepared each experimental day. Nifedipine, prozasin (hydrochloride), PPADS, TTX, uridine 5-triphosphate; trisodium salt hydrate (UTP), and U-73122 were made as stock solutions. These were stored at -20°C, stored at 4°C, and diluted to final concentration before using.
Nifedipine (10 M) and 2 M prozasin were always added in Ringer solution at 30 min before experimental recordings. The effects of other drugs (Apyrase, EGTA, suramin, PPADS, TTX, CGS-15943, U-73122, and U3343) were always examined 30 min after application.
Ca 2ϩ indicator loading procedures
Loading Ca 2ϩ indicators into SCs can be achieved either by microelectrode injection or by bath loading with acetoxymethyl (AM) ester. For microelectrode injection, the tissue was pinned to a 3-mlcapacity Perspex recording bath that had a thin layer of Sylgard in the bottom. The tissue chamber was continuously perfused with warm (30 -33°C) Ringer solution at a rate of 3 ml/min. The nuclear region of the somata (cell body) of Schwann cells on the surface of the vas deferens could be identified under transmitted light. Iontophoretic injection was used to fill Schwann cells with fluorescent Ca 2ϩ indicator dye through a sharp microelectrode. The microelectrode was filled with loading solution of composition 1 M K-acetate with 5-10 M Oregon Green 488 bis-(o-aminophenoxy)-N,N,NЈ,NЈ-tetraacetic acid (BAPTA)-1 dextran Ca 2ϩ indicator (O-6798, Molecular Probes, Eugene, OR). After achieving a stable impalement, a positive current (Ͻ0.1 nA) was applied through the microelectrode controlled by an AxoClamp 2B voltage-clamp amplifier (Axon Instruments, Union City, CA) over a period of 30 -90 s. For AM ester loading, the preparations were incubated in a loading solution, containing 2-4 M fluo-3 AM, the membrane-permeant form of the fluorescent Ca 2ϩ indicator (F-14218, Molecular Probes), for a period of 150 -180 min at 24 -26°C. Sometimes, 0.02% (wt/vol) of pluronic acid (F-127, Molecular Probes) was used to facilitate cell loading of AM ester (see Jahromi et al. 1992) . To maintain physiological pH, the loading solution was continually bubbled with 95% O 2 -5% CO 2 . The Ca 2ϩ indicator loaded vas deferens was then placed in a beaker filled with bubbling Ringer solution or pinned down in the recording bath where it was washed for Ն45 min at room temperature before any further experimental procedures to remove any nonspecific staining. All preceding procedures were performed in the dark.
Whole-mount immunolabeling
Vas deferens were fixed using 2% paraformaldehyde for 25 min, then washed for Ն30 min with PBS (pH 7.4). Preparations were then permeabilized in -20°C methanol for 10 min and washed again with PBS for 45 min. The vas deferens were then rinsed with PBS containing 0.3% triton X-100 and 0.2% bovine serum albumin for another 60 min to block nonspecific staining. Vas deferens were incubated in 1:1,000 diluted primary antibodies S-100␤, (Monoclonal Anti-S-100, ␤-subunit, clone SH-B1; S2532, Sigma) overnight at room temperature. After incubation in the primary antibody, the vas deferens was rinsed in three changes of PBS for 30 min, then incubated in diluted (1:500) secondary antibody [Alexa Fluor 488 IgG (HϩL), A11029, Sigma] for 90 min. The preparations were finally rinsed for 40 min with PBS before further studies. For negative control experiments, preparations were treated similarly, except that the primary antibody was omitted.
Local ATP, UTP application
Agonists were applied locally on Schwann cells using 2-m tip diameter micropipettes, containing either ATP or UTP solutions. A micropipette was positioned at a SC soma (20 -30 m away with ϳ30°angle) under visual control at high magnification (ϫ40 waterimmersion objective). Local ejection of either ATP or UTP was achieved by giving a short pulse (150 -250 ms) of positive air pressure (Ͻ10 psi) to the micropipette with a Picospritzer II (CV General Valve, Fairfield, NJ). The actual time for ejection was controlled by a Master-8 programmable pulse generator (AMPI, Jerusalem, Israel), which was triggered by computer. ATP or UTP were ejected from the micropipette in the opposite direction to that of the incoming flow of bath solution. Schwann cells were first examined for their response to the application of drugs at the edge of the vas deferens furthest removed from the incoming solution; subsequently SCs were examined for responses at successive sites, Ն60 -100 m apart, further removed from this edge. This ensured that SCs were not repeatedly exposed to drug application. Concentrations of 10 M of ATP and UTP were generally used as higher concentrations (100 M) could initiate muscle contraction. Pressure application of Ringer solution alone did not induce any Ca 2ϩ changes in SCs.
Stimulation of sympathetic nerve
The stimulation electrode consisted of two parallel fine epoxyinsulated tungsten wires separated by 40 -80 m. After we chose a loaded Schwann cell, the Y-shaped tip of the stimulation electrode was placed on the surface of the preparation, 30 -40 m away from the cell and straddling strings of varicosities. Electrical current was generated from an isolated stimulator (Digitimer, model DS2) using a pulse duration of 0.08 ms. The voltage applied (always Ͻ20 V) was adjusted so as to avoid causing muscle contraction. Stimulation trains of 5 Hz for 10 s were most often used and these were controlled by a Master-8 pulse generator.
Ca2
ϩ imaging of Schwann cells
Fluo-3 AM fluorescent dye was excited using a mercury arc lamp reflected light fluorescence attachment on an upright Olympus Optical microscope (model BX50WI, Tokyo, Japan). An Olympus Optical fluorescein wide band filter WIB, which combined dichroic mirror DM505, excitation filter BP460-490 (model U-MIB), and barrier filter BA515IF (model MBA530W25) was used to view fluo-3 AM. To minimize photo damage, a 6% neutral density filter was always inserted in the excitation light path, and sometimes another 25% filter was added to attenuate to 1.5% of maximum intensity. Fluorescence was observed through an Olympus Optical ϫ40 water-immersion objective (model LUM PlanFI/IR 0.80 numerical aperture; Olympus) using a CCD camera (model WV-BP-310; Panasonic, Secaucus, NJ). Images were acquired using a Scion (Frederick, MD) LG3 frame grabber. Images were taken and processed by using National Institutes of Health Image 1.63 program (available from the user remote location http://rsb.info.nih.gov/nih-image/). Images that demonstrated the distribution of SCs (for example, Figs. 1 and 2) were taken by integrating 32 frames. Ca 2ϩ transients of SCs were captured using single frames at rates of 5 frames/s, and the exact time of frame acquisition stamped on each image. All recording were performed at 31-33°C.
Images were analyzed using the National Institutes of Health Image 1.63 program. On the first control image, a region of interest was defined which encompassed a single SC. The mean intensity from a region of interest of exactly the same size and geometry was measured on all images of a given cell. Any movement of the cell over the course of the experiment was corrected for by an automated procedure, written in the macro programming language of National Institutes of Health Image, which tracked the cell between every frame based on the strongest local fluorescent signal compared with the background. The recording data were rejected if the SC had a vertical movement during image capturing as indicated by a spot adjacent to the SC of interest. The relative changes in fluorescence intensity in a SC were expressed as ⌬F/F ϭ 100 ϫ (F Ϫ F o )/F o , where F is the fluorescence intensity after ATP or UTP application or nerve stimulation, and F o is the averaged fluorescence intensity of a cell over a 10-s period before any nerve stimulation or drug application. Failure to obtain a change in Ca 2ϩ (⌬[Ca 2ϩ ] s ) was taken to occur if the peak pixel intensity was Ͻ4 times the SD of the background. These experimental data were rejected if there was dye saturation. The intensity of dye loading in SCs, in general, was not uniform, even between nearby SCs located on the same string.
Statistics
Results are presents as means Ϯ SE. A Student's unpaired ttest was used when data were compared between different groups by using the Microsoft Excel software. Statistical significance was determined at a confidence level of 95%. N p indicates the number of preparations used, whereas N s refers the number of cells studied.
R E S U L T S
Distribution of Schwann cells on the surface of the vas deferens
Exposure of the vas deferens to the calcium indicator fluo-3 AM for 180 min reveals a network of stained Schwann cells but in nearly all cases does not stain either the axons or the smooth muscle cells (Fig. 1, A and B) . Small axon bundles, observed with transmitted light, are accompanied by SCs with intensely stained cytoplasm of the cell body ϳ5 m diameter (Fig. 1A) . On occasions more than one SC body can be found in a cross-section through the bundle (Fig. 1A) . Single SCs, sequentially arranged into a string, are observed to leave the small axon bundles at intervals along their length (Fig. 1B) . These are presumably associated with single strings of varicosities that can be observed to leave small axon bundles. This was confirmed by observing, on occasions, both SCs and the strings of varicosities that accompanied them as a consequence of both being labeled with fluo-3 AM (Fig. 1, C and D) . Cells filled with calcium indicator were confirmed as SCs by labeling them with anti-S100 (Fig. 1E) . In general, there was nonuniformity in intensity of fluo-3 AM dye loading in SCs. This could even differ between nearby SCs located on the same string (data not be shown).
Individual SCs in a string could be injected with calcium dyes, such as Oregon Green 488 BAPTA-1 dextran, at the level of their cell bodies. Such strings of SCs were first identified with transmitted light (Fig. 2D ) and a microelectrode filled with dye, positioned over a cell body, which was then impaled, filling the SC with dye (Fig. 2, A and C) . In general such SCs were then observed to posses one or more thin long processes, proceeding from opposite poles of the ellipsoidal cell body (Fig. 2, A and C) . On some occasions, the nearby varicose axon was also impaled (Fig. 2B) , revealing the close proximity of nerve terminal and SC.
Identification of Schwann cells
To confirm our criteria for the identification of SCs, images were captured of calcium-labeled SCs on which pharmacological studies had been carried out (Fig. 1Ea) . Whole preparations from which these images had been captured were then rinsed with Ringer solution for ϳ4 h until no calcium fluorescence could be observed. Preparations were then processed for immunohistochemistry, and the presence of anti S-100 on the SCs previously labeled with calcium indicator revealed (Fig.  1Eb ). The anti S-100 labeling of SCs was the same as that which we have reported previously (Barden et al. 1999 ). These observations confirm our criteria for the identification of SCs at nerve terminals.
Spontaneous calcium transients in individual terminal Schwann cells
Occasionally, spontaneous calcium transient could be observed in SCs. Figure 3A shows nine images of a SC taken during a spontaneous calcium transient (⌬ [Ca 2ϩ ] s ) with zero time indicating the moment of peak ⌬ [Ca 2ϩ ] s . It will be noted that before the transient the two main processes emanating from the soma of the SC are barely visible (Ϫ0.5 s), whereas during the peak of the transient (0 s) they are clearly delineated. The ⌬[Ca 2ϩ ] s declined following the peak over a few seconds back to baseline calcium levels. The peak ⌬[Ca 2ϩ ] s could be quite different for different SCs (see Fig. 3 , B and C). ] s of the other SC had only declined by ϳ25% (Fig. 4B) (Fig. 4D) .
Evoked calcium transients in individual Schwann cells
The
] s responses to successive trains of nerve impulses greatly declined in amplitude. Figure 5A ATP may be metabolized to adenosine by ecto-enzymes existing in the junctional cleft (Salter et al. 1993; Ziganshin et al. 1994 The preceding observations prompted us to investigate whether purinergic receptors provide a major contribution to the eliciting of ⌬[Ca 2ϩ ] s due to action of ATP. To test the involvement, two nonspecific purinergic receptors antagonists were used, suramin and PPADS. These two antagonists have been reported to be effective at blocking most P2X and P2Y receptor subtypes (Ralevic and Burnstock 1998) . The percentage of SCs responding to local application of ATP in the presence of suramin (100 M), that is had a ⌬F/F Ͼ0.8, was only slightly reduced compared with controls (61.8% compared with 77.2%; P Ͻ 0.02; N s ϭ 34 from N p ϭ 5; see Fig.  6Ad ), although the amplitude of ⌬F/F was much smaller (2.98 Ϯ 1.16 compared with 7.97 Ϯ 1.06, P Ͻ 0.05; see Fig.  6Ac ). Thus the frequency distribution of SCs responding to ATP with a particular peak ⌬[Ca 2ϩ ] s (Fig. 6Ba ) was very skewed toward low ⌬ [Ca 2ϩ ] s in the presence of suramin (Fig.  6Bb) .
The effect of PPADS, an antagonist of P2X1 to P2X3, P2X5, P2X7, P2Y1, P2Y4, and P2Y6 receptors, was also tested. To avoid unnecessary side effects of PPADS, such as inhibiting IP 3 -induced [Ca 2ϩ ] i mobilization we started with 5 M concentration. The percentage of SCs responding to local application of ATP decreased from 77.2 to 65.2% (N s ϭ 23 from N p ϭ 4), but this was not significant (P Ͼ 0.2). However, the mean peak ⌬F/F was smaller than controls (compare Fig.  6B, c with a) . It dropped from control value of 7.97 Ϯ 1.06 to 4.38 Ϯ 1.56 (P Ͻ 0.05). The percentage of success in responding to ATP in the presence of 10 M PPADS was significantly decreased to 21.4% (P Ͻ 0.0001). The averaged ⌬F/F peak in SCs that did respond also declined in this concentration of PPADS to 1.15 Ϯ 0.16 (N s ϭ 28 from N p ϭ 4; P Ͻ 0.0001). The distribution of ⌬F/F is indicated in Fig. 6Bc 
D I S C U S S I O N
Schwann cells on the surface of the vas deferens
Bundles of up to five axons, together with single axons, occur frequently on the surface of the mouse vas deferens as has been ascertained by examining serial sections of the muscle with the electron microscope (Cottee et al. 1996; Lavidis and Bennett 1993) or staining the mitochondria within the axon with the fluorescent dye, 3,3-diethyloxardicarbocyanine iodide Bennett 1992, 1993) . The varicosities of axons at the surface release ATP which generates excitatory junctional currents (Karunanithi et al. 1993) . These varicosities are at least partially ensheathed in Schwann, as varicose axons do not loose their Schwann sheath until ϳ10 -60 m before termination of the axon (Gabella 1995; Merrillees 1968) . The study of ⌬ [Ca 2ϩ ] s in the present work was confined to single strings of SCs, identified both on loading with calcium indicators as well as immunohistochemically with antibodies to the SC marker S100 (see Barden et al. 1999 ). These SCs were probably associated with single strings of varicosities, whereas strings of multiple SCs in close juxtaposition were probably associated with axon bundles. On occasion, a single string of varicosities was labeled with the calcium indicator and shown to be in close relation with a string of SCs. (O'Connor et al. 1999 ). In addition, we have loaded SCs by injection of the calcium indicator rather than using the acetylmethyl form and shown ] s is reduced by suramin and assuming that the action of this drug is to block P2 receptors. There are two identified sources of ATP in the mammalian vas deferens on nerve stimulation: one of these is the nerve terminal (Sneddon et al. 1982) and the other the muscle on ␣-adrenoceptor or P2X receptor activation, the latter occurring even in the absence of muscle contraction (Katsuragi et al. 1991; Vizi and Burnstock 1988; Vizi et al. 1992 Liu and Bennett 2003) , so that we cannot exclude the possibility that an autocrine release of ATP occurs from the SCs.
Calcium transients in the Schwann cell versus those in the varicosities
The possibility that other transmitters than ATP are contributing to the nerve evoked SC response must be entertained. Immunohistochemistry indicates that there are five different classes of pelvic neurons that innervate the rat vas deferens, of which the great preponderance are noradrenaline (NAd) and neuropeptide (NPY) containing (ϳ70%). The remaining neurons contain vasoactive intestinal peptide (VIP; ϳ15%), NPY (5%), NPY plus VIP (5%) or galanin (Gal; ϳ2%) (Keast 1992) . The VIP neurons are cholinergic as are the NPY-, NPY ϩ VIP-, and Gal-containing neurons so that ϳ30% of the nerves are cholinergic (Keast 1995; Wanigasekara et al. 2003) . Sympathetic neurons (receiving an innervation from the hypogastric nerve) are either noradrenergic and contain NPY or cholinergic and contain VIP. Parasympathetic neurons (receiving an innervation from the pelvic nerve) are almost all cholinergic and contain either VIP or NPY or both (Keast 1995; Wanigasekara et al. 2003) . The NAd ϩ NPY-containing neurons innervate the longitudinal and circular muscle coats as do the NPY, NPY ϩ VIP and Gal neurons, whereas the VIP neurons, which are probably cholinergic, mainly innervate the lamina propria (Kaleczye 1998; Keast 1992) . Sensory axons, containing calcitonin gene-related peptide (CGRP) and substance P, are also found in the muscle coats (Kaleczyc 1998) , although the proportion of axons in the rodent vas deferens that are sensory is not known. These considerations show that there are a variety of transmitters, besides ATP, that have the potential to act on SCs on stimulation of the mammalian vas deferens nerve supply.
The question arises as to why so few SCs respond to nerve stimulation (ϳ25%) compared with those that respond to the application of ATP (ϳ80%). The most likely reason is that we have failed to stimulate the nerves associated with the SC recorded from. Preparing the vas deferens for dye loading of SCs, and their subsequent exposure to local ATP application, involves removing some of the epimysium and perimysium. This certainly damages part of the nerve supply and so has the potential of interrupting impulse traffic between the site of intramural nerve stimulation and the area containing the SCs of interest.
Physiological frequencies of activation of Schwann cells
Is the frequency of stimulation necessary to elicit ⌬[Ca 2ϩ ] s , namely Ͼ5Hz, is outside the physiological range? Preganglionic nerves to the mammalian superior cervical ganglion fire with a normal upper frequency of ϳ6 Hz (Janig 1988) , reaching as high as 40 Hz during inspiration (Boczek-Funcke et al. 1992) . This is mirrored by postganglionic sympathetic nerves that may fire with a rhythm reaching 6 Hz (Gebber et al. 1990) , with a mean within-burst firing rate of ϳ19 Hz (Macefield et al. 1994 ] s in response to applied ATP was completely eliminated by blocking the IP 3 pathway or emptying the calcium stores with caffeine, suggesting that a metabotropic P2Y subclass of the P2 receptors was involved. This indicates that the these SC's, like all other mammalian SCs studied, possess P2Y receptors (see, for example, Lyons et al. 1994; TakahashiIwanaga et al. 2004) . Furthermore, the action of UTP in producing ⌬ [Ca 2ϩ ] s suggests that P2Y2 or P2Y4 receptors are present on mammalian SCs (von Kugelgen and Wetter 2000) . However, whether the P2X receptors observed immunohistochemically on these SCs by Barden et al. (1999) (Robitaille 1995) . However, terminal SCs at the somatic mammalian neuromuscular junction elevate [⌬Ca 2ϩ ] s through the nerve terminal release of adenosine, which acts on A1 adenosine receptors, whereas P2 receptors for ATP do not appear to be present (Rochon et al. 2001) . This is in contrast to the present study, which shows that both nerve released and applied ATP acts directly on P2 receptors, whereas adenosine does not much affect the SCs. There is then a heterogeneity of mechanisms whereby [⌬Ca 2ϩ ] s is elevated by ATP for the SCs found at mammalian autonomic compared with mammalian somatic neuromuscular junctions. Whether such heterogeneity exists for SCs at preterminal axons compared with those at the terminals with their high density of varicosities remains for investigation.
Sources of calcium for ⌬[Ca 2ϩ ] s in SCs
Although we have provided evidence for the ⌬[Ca 2ϩ ] s due to ATP arising from calcium release from internal stores, there has been no investigation of the process of SC calcium sequestration. The ⌬[Ca 2ϩ ] s at the amphibian neuromuscular junction due to nerve stimulation is at least in part sequestered by SC endogeous buffers (Castonguay and Robitaille 2001 ; see also Castonguay and Robitaille 2002) . We have shown that depleting calcium from internal stores in the SC with, for example, caffeine, completely abolishes ⌬[Ca 2ϩ ] s. Furthermore, reducing the extracellular calcium concentration to zero (with 0 calcium and EGTA) has no effect. This result would be understandable if only P2Y metabotropic receptors existed on SCs in this organ, but immunohistochemical studies show that P2X1 and P2X3 ionotropic receptors are present on these SCs (Barden et al. 1999) . There is evidence for such ionotropic P2X receptors on Schwann cells at the frog neuromuscular junction (Robitaille 1995) We thank G. Macleod for helpful suggestions and a critical reading of the manuscript.
